As for Ebola, there is absolutely no market at all, so the only reason we have two vaccines in late-stage clinical trials now, is actually because of a somewhat misguided fear.
No caso do ébola,  non hai mercado en absoluto, a única razón pola que temos dúas vacinas  nas últimas fases de ensaio clínico, ten que ver cun certo medo infundado.